In the future, our team will conduct lentivirus transfection mediated recovery of function tests to more accurately confirm that DHIE can inhibit PLK1, inhibit or reactivate different subtypes of p53, and arrest the cell cycle of breast cancer. The gene discussed is TP53; the disease is breast cancer.